HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,685,152 | +15.5% | 197,423 | +9.8% | 0.16% | +5.2% |
| Q2 2023 | $15,313,541 | +13.3% | 179,863 | +10.1% | 0.15% | +24.4% |
| Q1 2023 | $13,512,578 | +787.8% | 163,294 | +743.8% | 0.12% | +41.4% |
| Q4 2022 | $1,522,035 | -26.6% | 19,352 | -30.9% | 0.09% | +93.3% |
| Q3 2022 | $2,073,000 | +12.5% | 28,003 | -0.9% | 0.04% | +25.0% |
| Q2 2022 | $1,842,000 | +15.1% | 28,255 | +11.6% | 0.04% | +38.5% |
| Q1 2022 | $1,601,000 | +7.2% | 25,324 | -10.1% | 0.03% | +13.0% |
| Q4 2021 | $1,494,000 | -28.4% | 28,162 | -4.7% | 0.02% | -30.3% |
| Q3 2021 | $2,086,000 | – | 29,549 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |